+499.5%
MRNA vs VFC
-6.8%
+506.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VFC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +2.4% | -4.6% | -3.0% |
| 7D | +5.5% | -1.6% | +7.1% | +5.9% |
| 30D | +158.7% | -11.6% | +170.4% | +169.9% |
| 3M | +182.1% | -18.1% | +200.2% | +196.1% |
| 6M | +151.8% | -27.4% | +179.2% | +175.0% |
| YTD | +393.6% | -24.8% | +418.4% | +431.5% |
| 1Y | +499.5% | -8.2% | +507.7% | +519.7% |
| All | +499.5% | -6.8% | +506.3% | +519.7% |
Cumulative growth
Daily Returns
Daily percentage return beside VFC.
Daily Out/Under-Performance
Portfolio return minus VFC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VFC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VFC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling